New course of development of prevention and cure of open second liver

Below the leader that learns in Ministry of Public Health and China cure, in foundation of Chinese hepatitis prevention and cure support energetically below, the Chinese head department that ill credit of liver of China cure society is met and affects ill credit to be able to combine formulate the guideline of prevention and cure of chronic hepatitis B will release formally on December 10. China cure learns liver disease to learn chapter chairman committee member, academician of Chinese Academy of Engineering, professor Zhuang Hui points out ministry of Beijing University medicine, want to control liver of our country second to shed a position high, the most efficient way is vaccine of liver of second of have an inoculation of crowd of easy to second liver feeling, should make good new life above all second liver vaccine is vaccinal, meanwhile, still answer crowd of other focal point and tall danger crowd to undertake have an inoculation of second liver vaccine. In addition, in recent years, content of bane of second liver disease-resistant comes out ceaselessly, this brings new remedial option to medical personnel undoubtedly, also give treat a disease the second liver patient that the heart cuts brought a hope. But experience tells us, if do not undertake normative disease-resistant poison is treated, not only bungle illness, and can bring heavy economic burden to the patient. Accordingly, the accurate remedial method that treats concept and standardization is very important to patient of broad medical personnel and chronic second liver. Stem from these considerations just about, many 80 expert that ill credit of liver of China cure society is met and catchs ill credit to meet whip and spur, in the formulate inside a short year guideline of prevention and cure of chronic hepatitis B , the purpose is the main idea that builds precautionary second liver in broad masses, vaccine of liver of executive second of crowd of easy to second liver feeling is vaccinal, the concept that second liver standardization treats is pushed in medical personnel. guideline of prevention and cure of chronic hepatitis B the principle that follows card medicine, bring into only by the program of accepted, prevention and cure that has gotten strict and clinical test and verify. Those who be worth to point out is: guideline of prevention and cure of chronic hepatitis B just help a doctor be made to second liver diagnosis and treatment and precaution correct and decision-making, not be all problems in mandatory standard; includes impossibly also or solving make a diagnosis and give treatment of chronic second liver. Accordingly, the clinician is in in the light of some when specific patient, answer to know the optimal and clinical evidence of second liver and resource of existing medical treatment adequately, on the foundation of the specific patient's condition that considering a patient in the round and its apiration, according to oneself knowledge and experience, make plan of sound diagnosis and treatment. Because the research progress of chronic second liver is rapid, guideline will be updated ceaselessly according to need and perfect. The second liver virus inside system of patient of liver of general and chronic second is kept clear of very hard thoroughly, involves diagnosis, detect index is more, treatment is more sophisticated, its curative effect and every patient is concerned in not contemporaneous immune function state, accordingly, chronic second liver is treated must because of the person different, because of different of from time to time. This is an enormous challenge to every medical personnel. China medicine can affect ill credit to meet chairman committee member, professor Weng Xinhua says hospital of Shanghai Mount Hua, the doctor must raise level of second liver make a diagnosis and give treatment quickly, because they are to let what benefit from benefit from treats the patient is true guardian , be cure of normative second liver is important the person that carry out. Current, medical personnel still makes a person anxious to the level of diagnosis and treatment of chronic second liver. The investigation that is aimed at medical personnel according to shows, the 45% public health worker that are surveyed do not know liver of second of make a diagnosis and give treatment should follow what kind of standard. Occupy foundation of Chinese hepatitis prevention and cure additionally to was announced 2005 the popular current situation of Chinese hepatitis and the problem analyses a report related its show, only the person of 19% is accepting disease-resistant poison at present this one right cure kind. Medical personnel treats recognizant lack to standardization, bring serious undesirable consequence to clinical cure. For example, according to guideline of international and our country's active second liver prevention and cure, the person that antigen of surface of second liver virus is carried, if their liver function lasts normal, hepatic histology does not have apparent pathological change, do not need to undertake disease-resistant poison is treated commonly. But be in our country clinical in, the person that antigen of many surface of second liver virus are carried was accepted or accepting such or in that way cure. Contrary, to a few chronic second that should accept treatment liver patient does not grant to treat, thereby incur loss through delay first-rate treats an opportunity, send indispose to control the patient's illness effectively. For example, still many clinicians think, the chronic second liver of HBeAg negative need not be treated. But be in guideline of prevention and cure of chronic hepatitis B in specific provision: Chronic hepatitis B has HBeAg positive and HBeAg negative two sort. HBeAg negative still can examine second liver virus in the blood of patient of chronic second liver, and liver function is abnormal, patient of liver of this kind of chronic second develops the sclerosis that it is liver, liver cancer more easily, accordingly, must have treatment. Can be imagined, in new treatment second liver medicaments enters the hour of the market quickly, if medical personnel treats level not to follow to go up, lack acknowledge to the normative cure of all sorts of medicaments, patient not only cannot seasonable benefit at optimal treatment program, and the likelihood makes already non-standard second liver treats the market more deviate the right path. (the exercitation edits: Plum apricot)